Alzheimer's disease (AD) is on track to become one of the defining public health challenges of our time. Every three seconds, ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback